ArticleBMC gastroenterology2023

Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.

Jolanta Skarbaliene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.